| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Revenue | $1.48B | +9.9% |
| Cost of Revenue | $1.18B | +7.8% |
| Gross Profit | $303.5M | +18.5% |
| R&D Expense | $15.2M | +61.7% |
| SG&A Expense | $136.3M | +16.7% |
| Operating Income | $167.2M | +20.0% |
| Interest Expense | $7.2M | -31.9% |
| Pre-tax Income | $169.6M | +33.6% |
| Income Tax | $43.9M |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $229.3M | +79.6% |
| Accounts Receivable | $20.6M | -65.1% |
| Inventory | $139.5M | +9.1% |
| Current Assets | $411.6M | +27.3% |
| Total Assets | $625.3M | +19.1% |
| Current Liabilities | $236.8M | +0.4% |
| Long-term Debt | $85.3M | -5.2% |
| Line Item | 2025-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $176.2M | +58.6% |
| Investing Cash Flow | -$23.9M | -50.9% |
| Financing Cash Flow | -$50.7M | -8.8% |
| +32.2% |
| Net Income | $127.7M | +21.0% |
| EPS (Basic) | $4.01 | +22.6% |
| EPS (Diluted) | $3.88 | +22.8% |
| Stockholders' Equity |
| $255.4M |
| +60.1% |